Perry J F, Poustchi H, George J, Farrell G C, McCaughan G W, Strasser S I
Centre of Clinical Research Excellence to Improve Outcomes in Chronic Liver Disease, University of Sydney, AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, 2050 NSW, Australia.
Clin Exp Med. 2005 May;5(1):1-13. doi: 10.1007/s10238-005-0058-3.
Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, and incidence rates in Western countries are on the rise. Despite many options, no ideal treatment yet exists for this highly malignant tumour, and management strategies have varied accordingly. This review summarises current strategies for the diagnosis and management of HCC.
肝细胞癌（HCC）是全球癌症死亡的主要原因之一，西方国家的发病率正在上升。尽管有多种治疗选择，但对于这种高度恶性肿瘤，目前尚无理想的治疗方法，相应地，管理策略也各不相同。本综述总结了目前肝细胞癌的诊断和管理策略。
